Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,748.00    -12.00 (-0.32%)
Bid:
3,748.00
Ask:
3,752.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Trading Statement

12 Nov 2024 07:00

RNS Number : 7756L
4imprint Group PLC
12 November 2024
 

12 November 2024

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides a scheduled update on the Group's trading and operations.

 

The Group has delivered a strong financial performance in difficult market conditions in the 10 month period up to the end of October 2024.

 

The Board is pleased to update the full year 2024 financial guidance given with the Interim results on 7 August 2024. Expectations for Group profit before tax remain unchanged and are within the current range of analysts' forecasts at just over $150m. Group revenue is expected to be around $1.37bn.

 

October year to date total order count was 2% higher than prior year. New customer orders were 9% below prior year to date, but encouragingly existing customer orders were up 6%, reflecting the quality of customers acquired under the new marketing mix. Combined with strong average order values at 2% above prior year, overall order revenue was 4% above the same time period in 2023.

 

The promotional products industry in our primary North American market has continued to present a challenging trading backdrop. Continuing uncertainty around economic conditions has translated into generally weaker levels of corporate confidence, compounded by specific macro factors over which the Group has no control, including elevated interest rates, severe weather events and the distraction arising from the US election cycle.

 

Although these factors have resulted in some pressure on revenue, performance across the remainder of the business has been very satisfactory. In particular, gross profit margin has remained strong at around 32% and the resilience and flexibility of the new marketing mix has enabled us to be agile in tailoring our marketing investment to the prevailing market conditions. The resulting double digit operating profit margin is a key factor underpinning our Group profit before tax performance.

 

With a cash balance of $137m at the end of October 2024, the Group remains highly cash generative and well financed.

 

Our experience is that less buoyant economic conditions represent a market share opportunity for 4imprint as our financial strength allows us to keep investing in the business and to take full advantage of the market recovery when it arrives.

 

The Board remains very confident in the Group's strategy, positioning and prospects.

 

 

For further information, please contact:

 

4imprint Group plc

MHP Group

Tel: + 44 (0) 20 3709 9680

Tel: + 44 (0) 7884 494112

Kevin Lyons-Tarr, Chief Executive Officer

Katie Hunt

David Seekings, Chief Financial Officer

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDFLFFZFLBFBX
Date   Source Headline
16th Oct 201711:13 amRNSEBT purchase
9th Oct 20172:25 pmRNSEBT purchase
22nd Sep 20172:12 pmRNSEBT Purchase
20th Sep 20174:06 pmRNSHolding(s) in Company
13th Sep 20173:24 pmRNSHolding(s) in Company
17th Aug 20178:59 amRNSHolding(s) in Company
3rd Aug 20179:06 amRNSDirector/PDMR Shareholding
1st Aug 20174:41 pmRNSSecond Price Monitoring Extn
1st Aug 20174:35 pmRNSPrice Monitoring Extension
1st Aug 20177:00 amRNSHalf-year Report
4th Jul 20172:58 pmRNSHolding(s) in Company
28th Jun 201710:18 amRNSHolding(s) in Company
22nd Jun 20173:11 pmRNSHolding(s) in Company
20th Jun 20179:29 amRNSNotice of Results
16th May 20179:30 amRNSHolding(s) in Company
11th May 20172:57 pmRNSEBT Purchase
11th May 20178:38 amRNSDirector/PDMR Shareholding
10th May 20174:30 pmRNSDirector/PDMR Shareholding
10th May 20172:25 pmRNSHolding(s) in Company
10th May 201712:06 pmRNSResult of AGM
9th May 20174:02 pmRNSHolding(s) in Company
9th May 20177:00 amRNSAGM Trading Statement
8th May 20179:38 amRNSHolding(s) in Company
4th Apr 20173:52 pmRNSAnnual Financial Report
30th Mar 20179:12 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSFinal Results
19th Jan 20177:00 amRNSTrading Update and Notice of Final Results
9th Dec 20164:35 pmRNSPrice Monitoring Extension
8th Dec 20164:12 pmRNSEBT Purchase
28th Nov 201612:01 pmRNSEBT Purchase
22nd Nov 201611:03 amRNSEBT Purchase
9th Nov 201612:07 pmRNSSecond Price Monitoring Extn
9th Nov 201612:02 pmRNSPrice Monitoring Extension
2nd Nov 20167:00 amRNSTrading Update
7th Oct 20169:27 amRNSHolding(s) in Company
3rd Oct 20168:43 amRNSHolding(s) in Company
12th Aug 20168:53 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSDirectorate Change
10th Aug 201611:10 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSHalf-year Report
16th Jun 20169:26 amRNSNotice of Results
19th May 20169:46 amRNSHolding(s) in Company
10th May 20164:39 pmRNSResult of AGM
10th May 201611:00 amRNSAGM Statement
9th May 201610:15 amRNSHolding(s) in Company
5th May 20168:33 amRNSHolding(s) in Company
3rd May 20168:38 amRNSTotal Voting Rights
25th Apr 20161:13 pmRNSHolding(s) in Company
19th Apr 201610:00 amRNSDirector/PDMR Shareholding
14th Apr 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.